Renalytix plc (NASDAQ:RNLX) recently disclosed in a Form 8-K filing with the Securities and Exchange Commission that a director, Daniel Levangie, has resigned from the Company’s Board of Directors and all related committees. The resignation of Mr. Levangie was effective as of October 31, 2024. Renalytix stated that Mr. Levangie’s decision to step down was […]